Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (1194)	3/3/1998 2:02:00 AM
From: The Gambler	Read Replies (6) \| Respond to of 2173

You predicted AMLN price to go as low as $2-$3. Do you think that the stock price will stay that low, and if you do, for how long will it stay at that level? From your previous posts, it seems that you have discounted the chances of any possibility that Amylin might be successful at type II diabetes. Is this based on their findings that the probability of a success is at best minimal to nothing or on some other reasons that we might not know? I'm looking forward to your reply, thank you.